Case Study: a leading biopharmaceutical company achieves 7% manufacturing cost savings with L.E.K. Consulting

a leading biopharmaceutical company unlocks $80 million in network savings with LEK Consulting

The leading biopharmaceutical company engaged LEK Consulting to optimize its global manufacturing network. Facing a potential downturn in demand, the client needed a strategy to reduce costs while maintaining business continuity and production flexibility, requiring a blueprint for network rationalization.

LEK Consulting provided a portfolio of network configuration options, including site divestment and outsourcing strategies, which enabled significant cost savings upwards of 7% ($80 million). This solution empowered the biopharma with a comprehensive financial model and risk assessment to make informed decisions, achieving meaningful near-term savings and providing the flexibility to swiftly rebalance capacity based on future demand.